US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 11.510
  • +0.100+0.88%
Close May 2 16:00 ET
  • 11.510
  • 0.0000.00%
Post 16:05 ET
530.55MMarket Cap-3.89P/E (TTM)

UroGen Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-26.70%-96.77M
-4.79%-13.62M
-59.92%-27.66M
-17.14%-23.75M
-22.97%-31.74M
12.77%-76.38M
40.25%-13M
1.78%-17.3M
16.22%-20.27M
-7.55%-25.81M
Net income from continuing operations
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
Operating gains losses
31.06%15.08M
117.35%6.06M
12.52%3.07M
7.43%3.34M
-9.54%2.6M
-17.87%11.5M
-6.63%2.79M
2.71%2.73M
-23.61%3.11M
-33.01%2.87M
Depreciation and amortization
-30.44%1.19M
-27.83%306K
-35.90%266K
-38.98%263K
-19.31%351K
-6.16%1.71M
-5.78%424K
-4.60%415K
-9.45%431K
-4.61%435K
Other non cash items
-228.70%-1.31M
-24.24%25K
-366.67%-592K
-37.18%223K
-337.87%-961K
-61.36%1.01M
-96.46%33K
-78.32%222K
-8.03%355K
43.26%404K
Change In working capital
47.87%4.93M
105.06%15.53M
-767.68%-9.15M
231.98%2.57M
-223.99%-4.01M
152.90%3.34M
866.07%7.57M
-154.89%-1.06M
63.86%-1.95M
65.90%-1.24M
-Change in receivables
-77.40%-4.86M
196.30%2.5M
-302.67%-5.39M
-8.13%-3.26M
509.00%1.29M
-177.51%-2.74M
20.73%-2.6M
22.71%2.66M
-43.70%-3.01M
-90.49%211K
-Change in inventory
-163.65%-3.55M
-143.37%-1.63M
-985.71%-152K
-141.72%-199K
-37.72%-1.57M
-272.38%-1.35M
-337.10%-671K
91.52%-14K
185.79%477K
-1,600.00%-1.14M
-Change in prepaid assets
75.12%1.44M
-9.54%5.21M
44.34%-1.85M
-197.57%-1.72M
79.90%-210K
122.61%820K
1,202.87%5.76M
-2,170.55%-3.32M
50.17%-577K
41.94%-1.05M
-Change in payables and accrued expense
58.66%10.65M
81.49%9.29M
-112.49%-1.89M
593.95%7.46M
-398.72%-4.21M
322.14%6.71M
9.83%5.12M
-198.23%-889K
26,975.00%1.08M
135.49%1.41M
-Change in other current assets
106.41%1.45M
-1,925.00%-219K
-60.50%303K
23.55%425K
323.28%940K
155.32%702K
104.46%12K
237.95%767K
225.09%344K
-149.11%-421K
-Change in other current liabilities
70.78%-237K
964.44%389K
29.77%-184K
22.62%-195K
1.98%-247K
50.91%-811K
51.09%-45K
7.09%-262K
80.51%-252K
-1,780.00%-252K
-Change in other working capital
--49K
---1K
--0
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-26.70%-96.77M
-4.79%-13.62M
-59.92%-27.66M
-17.14%-23.75M
-22.97%-31.74M
12.77%-76.38M
40.25%-13M
1.78%-17.3M
16.22%-20.27M
-7.55%-25.81M
Investing cash flow
Cash flow from continuing investing activities
-2,062.96%-20.61M
634.39%60.62M
-26,720.95%-106.75M
222.53%12M
115.60%13.52M
-189.91%-953K
-149.09%-11.34M
101.13%401K
2,563.58%3.72M
-53.88%6.27M
Net PPE purchase and sale
-52.06%-295K
-105.36%-115K
4.00%-96K
-460.00%-84K
--0
23.62%-194K
-330.77%-56K
34.64%-100K
76.19%-15K
8.00%-23K
Net investment purchase and sale
-2,576.94%-20.32M
638.06%60.74M
-21,388.22%-106.65M
223.48%12.08M
114.81%13.52M
-157.76%-759K
-148.82%-11.29M
101.42%501K
4,344.32%3.74M
-53.80%6.29M
Cash from discontinued investing activities
Investing cash flow
-2,062.96%-20.61M
634.39%60.62M
-26,720.95%-106.75M
222.53%12M
115.60%13.52M
-189.91%-953K
-149.09%-11.34M
101.13%401K
2,563.58%3.72M
-53.88%6.27M
Financing cash flow
Cash flow from continuing financing activities
66.44%194.62M
77.50%71K
-65.88%39.61M
70,029.37%100.29M
8,045.60%54.66M
20.38%116.93M
-99.84%40K
10,442.87%116.08M
285.71%143K
-99.05%671K
Net issuance payments of debt
--24.49M
--0
----
----
----
--0
--0
----
----
----
Net common stock issuance
124.43%151.17M
--0
-77.73%15M
--81.51M
--54.66M
--67.36M
--0
--67.36M
--0
--0
Proceeds from stock option exercised by employees
-61.75%18.96M
77.50%71K
-99.76%115K
13,030.07%18.78M
--0
3,180.81%49.57M
-89.42%40K
4,261.59%48.72M
793.75%143K
--671K
Cash from discontinued financing activities
Financing cash flow
66.44%194.62M
77.50%71K
-65.88%39.61M
70,029.37%100.29M
8,045.60%54.66M
20.38%116.93M
-99.84%40K
10,442.87%116.08M
285.71%143K
-99.05%671K
Net cash flow
Beginning cash position
70.44%95.82M
4.88%125.99M
954.28%220.8M
254.08%132.26M
70.44%95.82M
23.33%56.22M
307.22%120.12M
-74.30%20.94M
-64.74%37.35M
23.32%56.22M
Current changes in cash
95.04%77.24M
293.72%47.07M
-195.59%-94.81M
639.49%88.54M
293.15%36.44M
272.37%39.6M
-190.93%-24.3M
290.71%99.18M
32.82%-16.41M
-131.27%-18.87M
End cash Position
80.61%173.06M
80.61%173.06M
4.88%125.99M
954.28%220.8M
254.08%132.26M
70.44%95.82M
70.44%95.82M
307.22%120.12M
-74.30%20.94M
-64.74%37.35M
Free cash flow
-26.76%-97.06M
-5.23%-13.73M
-59.55%-27.76M
-17.46%-23.83M
-22.86%-31.74M
12.80%-76.57M
40.03%-13.05M
2.06%-17.4M
16.38%-20.29M
-7.53%-25.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -26.70%-96.77M-4.79%-13.62M-59.92%-27.66M-17.14%-23.75M-22.97%-31.74M12.77%-76.38M40.25%-13M1.78%-17.3M16.22%-20.27M-7.55%-25.81M
Net income from continuing operations -24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M
Operating gains losses 31.06%15.08M117.35%6.06M12.52%3.07M7.43%3.34M-9.54%2.6M-17.87%11.5M-6.63%2.79M2.71%2.73M-23.61%3.11M-33.01%2.87M
Depreciation and amortization -30.44%1.19M-27.83%306K-35.90%266K-38.98%263K-19.31%351K-6.16%1.71M-5.78%424K-4.60%415K-9.45%431K-4.61%435K
Other non cash items -228.70%-1.31M-24.24%25K-366.67%-592K-37.18%223K-337.87%-961K-61.36%1.01M-96.46%33K-78.32%222K-8.03%355K43.26%404K
Change In working capital 47.87%4.93M105.06%15.53M-767.68%-9.15M231.98%2.57M-223.99%-4.01M152.90%3.34M866.07%7.57M-154.89%-1.06M63.86%-1.95M65.90%-1.24M
-Change in receivables -77.40%-4.86M196.30%2.5M-302.67%-5.39M-8.13%-3.26M509.00%1.29M-177.51%-2.74M20.73%-2.6M22.71%2.66M-43.70%-3.01M-90.49%211K
-Change in inventory -163.65%-3.55M-143.37%-1.63M-985.71%-152K-141.72%-199K-37.72%-1.57M-272.38%-1.35M-337.10%-671K91.52%-14K185.79%477K-1,600.00%-1.14M
-Change in prepaid assets 75.12%1.44M-9.54%5.21M44.34%-1.85M-197.57%-1.72M79.90%-210K122.61%820K1,202.87%5.76M-2,170.55%-3.32M50.17%-577K41.94%-1.05M
-Change in payables and accrued expense 58.66%10.65M81.49%9.29M-112.49%-1.89M593.95%7.46M-398.72%-4.21M322.14%6.71M9.83%5.12M-198.23%-889K26,975.00%1.08M135.49%1.41M
-Change in other current assets 106.41%1.45M-1,925.00%-219K-60.50%303K23.55%425K323.28%940K155.32%702K104.46%12K237.95%767K225.09%344K-149.11%-421K
-Change in other current liabilities 70.78%-237K964.44%389K29.77%-184K22.62%-195K1.98%-247K50.91%-811K51.09%-45K7.09%-262K80.51%-252K-1,780.00%-252K
-Change in other working capital --49K---1K--0----------------------------
Cash from discontinued investing activities
Operating cash flow -26.70%-96.77M-4.79%-13.62M-59.92%-27.66M-17.14%-23.75M-22.97%-31.74M12.77%-76.38M40.25%-13M1.78%-17.3M16.22%-20.27M-7.55%-25.81M
Investing cash flow
Cash flow from continuing investing activities -2,062.96%-20.61M634.39%60.62M-26,720.95%-106.75M222.53%12M115.60%13.52M-189.91%-953K-149.09%-11.34M101.13%401K2,563.58%3.72M-53.88%6.27M
Net PPE purchase and sale -52.06%-295K-105.36%-115K4.00%-96K-460.00%-84K--023.62%-194K-330.77%-56K34.64%-100K76.19%-15K8.00%-23K
Net investment purchase and sale -2,576.94%-20.32M638.06%60.74M-21,388.22%-106.65M223.48%12.08M114.81%13.52M-157.76%-759K-148.82%-11.29M101.42%501K4,344.32%3.74M-53.80%6.29M
Cash from discontinued investing activities
Investing cash flow -2,062.96%-20.61M634.39%60.62M-26,720.95%-106.75M222.53%12M115.60%13.52M-189.91%-953K-149.09%-11.34M101.13%401K2,563.58%3.72M-53.88%6.27M
Financing cash flow
Cash flow from continuing financing activities 66.44%194.62M77.50%71K-65.88%39.61M70,029.37%100.29M8,045.60%54.66M20.38%116.93M-99.84%40K10,442.87%116.08M285.71%143K-99.05%671K
Net issuance payments of debt --24.49M--0--------------0--0------------
Net common stock issuance 124.43%151.17M--0-77.73%15M--81.51M--54.66M--67.36M--0--67.36M--0--0
Proceeds from stock option exercised by employees -61.75%18.96M77.50%71K-99.76%115K13,030.07%18.78M--03,180.81%49.57M-89.42%40K4,261.59%48.72M793.75%143K--671K
Cash from discontinued financing activities
Financing cash flow 66.44%194.62M77.50%71K-65.88%39.61M70,029.37%100.29M8,045.60%54.66M20.38%116.93M-99.84%40K10,442.87%116.08M285.71%143K-99.05%671K
Net cash flow
Beginning cash position 70.44%95.82M4.88%125.99M954.28%220.8M254.08%132.26M70.44%95.82M23.33%56.22M307.22%120.12M-74.30%20.94M-64.74%37.35M23.32%56.22M
Current changes in cash 95.04%77.24M293.72%47.07M-195.59%-94.81M639.49%88.54M293.15%36.44M272.37%39.6M-190.93%-24.3M290.71%99.18M32.82%-16.41M-131.27%-18.87M
End cash Position 80.61%173.06M80.61%173.06M4.88%125.99M954.28%220.8M254.08%132.26M70.44%95.82M70.44%95.82M307.22%120.12M-74.30%20.94M-64.74%37.35M
Free cash flow -26.76%-97.06M-5.23%-13.73M-59.55%-27.76M-17.46%-23.83M-22.86%-31.74M12.80%-76.57M40.03%-13.05M2.06%-17.4M16.38%-20.29M-7.53%-25.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 81.620
Sample Name
Sample Code
 11.660
Sample Name
Sample Code
 6.080
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.310
5
Enerpac Tool
EPAC
41.900
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick Show More
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 597.020
Sample Name
Sample Code
 150.730
Sample Name
Sample Code
 394.370
4
Toll Brothers
TOL
104.330
5
MARA Holdings
MARA
14.480
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 125.760
Sample Name
Sample Code
 597.020
Sample Name
Sample Code
 179.280
4
Oracle
ORCL
150.730
5
ASML Holding
ASML
690.330
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 0.1893
Sample Name
Sample Code
 8.390
Sample Name
Sample Code
 10.970
4
Argo Blockchain
ARBK
0.4265
5
The9 Ltd
NCTY
12.300
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -